| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Human Oncology [T. A. T., K. K., M. N. G.], Department of Oncology, McArdle Laboratory for Cancer Research [M. N. G.], and Environmental Toxicology Center [T. A. T., M. N. G.], University of Wisconsin-Madison, Madison, Wisconsin 53792
Exclusive activation of either the Harvey-, Kirsten-, or N-ras gene is often found in human and rodent cancers, although the mechanisms responsible for tissue-specific ras gene activation are poorly understood. In this study, the contribution of ras gene expression and Ras protein activity to the tissue-specificity of ras gene activation was investigated using the rat mammary carcinogenesis model where ras activation, when it occurs, is exclusively in the Harvey ras gene. Differential ras gene expression was examined in mammary tissue from virgin, pregnant, and lactating rats. Harvey ras expression was 1.52-fold higher than Kirsten ras or N-ras at each adult stage of development, with the highest ras levels expressed during pregnancy. The modest difference in total mRNA expression found between the independent members of the ras gene family is unlikely to fully account for the exclusive tissue-specificity of Harvey ras activation observed in rat mammary carcinogenesis. Thus, the role of Ras protein specificity was studied by infecting the mammary gland of virgin rats in situ with replication-defective retroviral vectors expressing either the activated or wild-type forms of Harvey- or Kirsten-ras. A 7-14-fold higher number of mammary carcinomas was observed after infection with vectors expressing the G35 to A activated Harvey ras gene product compared with those expressing G35 to A activated Kirsten ras. Mammary carcinomas also developed from infusion of vectors expressing wild-type Harvey ras, but not wild-type Kirsten ras. These data suggest the importance of the Ras protein itself in determining the specificity of the highly homologous Ras family members in organ-specific carcinogenesis.
1 Supported by NIH Grants CA77527 and CA44387 and Predoctoral Fellowship DAMD17-94-J-4104 (to T. A. T.) from the United States Army Medical Research Material Command.
2 To whom requests for reprints should be addressed, at University of Wisconsin-Madison, Department of Oncology, CSC K4/334, 600 Highland Avenue, Madison, WI 53792.
Received 5/20/98. Accepted 9/17/98.
This article has been cited by other articles:
![]() |
D. R. McFarlin and M. N. Gould Rat mammary carcinogenesis induced by in situ expression of constitutive Raf kinase activity is prevented by tethering Raf to the plasma membrane Carcinogenesis, June 1, 2003; 24(6): 1149 - 1153. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. McFarlin, M. J. Lindstrom, and M. N. Gould Affinity with Raf is sufficient for Ras to efficiently induce rat mammary carcinomas Carcinogenesis, January 1, 2003; 24(1): 99 - 105. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kim, M. J. Lindstrom, and M. N. Gould Regions of H- and K-Ras That Provide Organ Specificity/Potency in Mammary Cancer Induction Cancer Res., March 1, 2002; 62(5): 1241 - 1245. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |